Berkeley Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,344
Closed -$209K 77
2023
Q3
$209K Hold
1,344
0.14% 76
2023
Q2
$222K Buy
1,344
+2
+0.1% +$323 0.15% 73
2023
Q1
$208K Buy
1,342
+2
+0.1% +$323 0.15% 74
2022
Q4
$237K Buy
1,340
+1
+0.1% +$173 0.18% 70
2022
Q3
$219K Buy
1,339
+1
+0.1% +$169 0.18% 72
2022
Q2
$237K Buy
1,338
+2
+0.1% +$356 0.19% 71
2022
Q1
$237K Buy
1,336
+1
+0.1% +$170 0.17% 88
2021
Q4
$228K Buy
1,335
+1
+0.1% +$164 0.15% 85
2021
Q3
$215K Buy
1,334
+1
+0.1% +$171 0.16% 81
2021
Q2
$220K Buy
1,333
+27
+2% +$4.47K 0.16% 77
2021
Q1
$215K Buy
1,306
+1
+0.1% +$162 0.16% 78
2020
Q4
$205K Buy
+1,305
New +$193K 0.17% 78

Other funds holding JNJ

Berkeley Inc's JNJ Position: Q4 2023 in Review

Berkeley Inc sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 1,344 shares — an estimated $209K sold.

Berkeley Inc first reported a position in JNJ in Q4 2020 and held it in 12 quarters. The position peaked at $237K in Q2 2022. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Berkeley Inc reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
  • Berkeley Inc sold 1,344 Johnson & Johnson shares in Q4 2023, an estimated $209K.
  • Berkeley Inc first reported a position in Johnson & Johnson in Q4 2020 and held it in 12 quarters.
  • Berkeley Inc's Johnson & Johnson position peaked at $237K in Q2 2022.
  • 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Berkeley Inc's 13F filing for Q4 2023, filed 4 Mar 2025.